Indian pharma market grew 12.1% in August, AWACS report

Indian pharmaceutical market (IPM) grew 12.1% in value and 4.8% in volumes, in the month of August on back of strong growth across all the therapy areas, according to market research firm AWACS.

IPM saw sales of Rs 16,239 crore during August.

The wholesale price index (WPI) inflation linked price hike allowed by the government has helped the pharma industry to increase by 10% on drugs under price control, along with monsoon linked infectious diseases.

The fastest growing categories are cardiac which grew at 13%, anti-infectives - 13% and gastrointestinal - 12%. Anti-diabetes and vitamins grew 9% respectively.

Augmentin of GSK, Glycomet of USV and Mixtard of Abbott, remain top-3 selling brands in India.